News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
320,634 Results
Type
Article (14772)
Company Profile (114)
Press Release (305740)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (99572)
Career Advice (570)
Deals (20554)
Drug Delivery (73)
Drug Development (40084)
Employer Resources (50)
FDA (7087)
Job Trends (7206)
News (171614)
Policy (15630)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (508)
Accelerated approval (15)
Adcomms (8)
Allergies (68)
Alliances (26560)
ALS (64)
Alzheimer's disease (583)
Antibody-drug conjugate (ADC) (114)
Approvals (7302)
Artificial intelligence (216)
Autoimmune disease (45)
Automation (13)
Bankruptcy (190)
Best Places to Work (5269)
BIOSECURE Act (9)
Biosimilars (122)
Biotechnology (47)
Bladder cancer (43)
Brain cancer (34)
Breast cancer (212)
Cancer (1647)
Cardiovascular disease (159)
Career advice (510)
Career pathing (13)
CAR-T (59)
CDC (6)
Celiac Disease (1)
Cell therapy (187)
Cervical cancer (9)
Clinical research (35048)
Collaboration (796)
Compensation (374)
Complete response letters (36)
COVID-19 (844)
CRISPR (44)
C-suite (462)
Cystic fibrosis (65)
Data (2255)
Denatured (18)
Depression (51)
Diabetes (151)
Diagnostics (1987)
Digital health (13)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (123)
Drug pricing (119)
Drug shortages (12)
Duchenne muscular dystrophy (85)
Earnings (37961)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (46035)
Executive appointments (580)
FDA (8362)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (538)
Gene editing (74)
Generative AI (18)
Gene therapy (171)
GLP-1 (454)
Government (1524)
Grass and pollen (4)
Guidances (187)
Healthcare (5090)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (73)
Immuno-oncology (20)
Indications (58)
Infectious disease (919)
Inflammatory bowel disease (88)
Inflation Reduction Act (7)
Influenza (31)
Intellectual property (134)
Interviews (78)
IPO (9283)
IRA (33)
Job creations (2154)
Job search strategy (449)
JPM (29)
Kidney cancer (9)
Labor market (28)
Layoffs (206)
Leadership (8)
Legal (3969)
Liver cancer (22)
Longevity (8)
Lung cancer (232)
Lymphoma (137)
Machine learning (15)
Management (17)
Manufacturing (436)
MASH (73)
Medical device (3013)
Medtech (3024)
Mergers & acquisitions (11981)
Metabolic disorders (471)
Multiple sclerosis (50)
NASH (14)
Neurodegenerative disease (92)
Neuropsychiatric disorders (40)
Neuroscience (1066)
Neurotech (1)
NextGen: Class of 2026 (2222)
Non-profit (732)
Now hiring (17)
Obesity (235)
Opinion (143)
Ovarian cancer (53)
Pain (125)
Pancreatic cancer (86)
Parkinson's disease (106)
Partnered (14)
Patents (263)
Patient recruitment (145)
Peanut (13)
People (32764)
Pharmaceutical (63)
Pharmacy benefit managers (20)
Phase 1 (9413)
Phase 2 (15039)
Phase 3 (12978)
Pipeline (2241)
Policy (136)
Postmarket research (1427)
Preclinical (3802)
Press Release (26)
Prostate cancer (100)
Psychedelics (17)
Radiopharmaceuticals (156)
Rare diseases (380)
Real estate (2969)
Recruiting (18)
Regulatory (12043)
Reports (18)
Research institute (665)
Resumes & cover letters (67)
Rett syndrome (5)
RNA editing (6)
RSV (25)
Schizophrenia (89)
Series A (95)
Series B (61)
Service/supplier (2)
Sickle cell disease (59)
Special edition (10)
Spinal muscular atrophy (83)
Sponsored (9)
Startups (1903)
State (2)
Stomach cancer (6)
Supply chain (51)
Tariffs (68)
The Weekly (45)
Vaccines (255)
Venture capital (32)
Weight loss (140)
Women's health (29)
Worklife (4)
Date
Today (6)
Last 7 days (215)
Last 30 days (795)
Last 365 days (12647)
2026 (1151)
2025 (12978)
2024 (15346)
2023 (17676)
2022 (23559)
2021 (24856)
2020 (23765)
2019 (18185)
2018 (14264)
2017 (16086)
2016 (14953)
2015 (18006)
2014 (14142)
2013 (11993)
2012 (12940)
2011 (13195)
2010 (12114)
Location
Africa (323)
Alabama (25)
Alaska (1)
Arizona (119)
Arkansas (3)
Asia (22919)
Australia (3000)
California (4150)
Canada (1604)
China (588)
Colorado (173)
Connecticut (193)
Delaware (143)
Europe (43666)
Florida (790)
Georgia (90)
Hawaii (1)
Idaho (15)
Illinois (394)
India (44)
Indiana (268)
Iowa (2)
Japan (258)
Kansas (82)
Kentucky (23)
Louisiana (6)
Maine (47)
Maryland (532)
Massachusetts (3176)
Michigan (115)
Minnesota (202)
Mississippi (5)
Missouri (38)
Montana (10)
Nebraska (9)
Nevada (52)
New Hampshire (16)
New Jersey (1615)
New Mexico (8)
New York (1204)
North Carolina (827)
North Dakota (2)
Northern California (1854)
Ohio (103)
Oklahoma (5)
Oregon (21)
Pennsylvania (938)
Puerto Rico (12)
Rhode Island (21)
South America (541)
South Carolina (17)
Southern California (1812)
Tennessee (81)
Texas (664)
United States (16249)
Utah (110)
Vermont (1)
Virginia (165)
Washington D.C. (43)
Washington State (294)
West Virginia (2)
Wisconsin (53)
Wyoming (1)
320,634 Results for "vyera pharmaceuticals llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Vyera Pharmaceuticals, LLC and Phoenixus AG Sign Asset Purchase Agreement to Sell Rights to Daraprim and Vecamyl
Vyera Pharmaceuticals, LLC and Phoenixus AG announced that they have entered into an Asset Purchase Agreement related to Daraprim and Vecamyl.
August 1, 2023
·
4 min read
Pharm Country
Tilde Sciences acquires Daraprim® and Vecamyl® from Vyera Pharmaceuticals
Tilde Sciences, a specialty pharmaceutical company, announced today that it has acquired two medicines, Daraprim® and Vecamyl® from Vyera Pharmaceuticals.
December 7, 2023
·
1 min read
Press Releases
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
December 17, 2025
·
3 min read
Press Releases
Kathy Spencer-Pike Joins NorthStar Medical Radioisotopes, LLC as Chief Commercial Officer
December 17, 2025
·
3 min read
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Press Releases
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
December 17, 2025
·
3 min read
Press Releases
Curonix LLC Announces Commercial Availability of the Freedom® Peripheral Nerve Stimulator (PNS) System as the Only Full-Body PNS Therapy Available in the United States for Craniofacial Pain
January 19, 2026
·
3 min read
Press Releases
CellRight Technologies, LLC Announces Update and Senior Leadership Changes
October 21, 2025
·
3 min read
Press Releases
Clongen Laboratories, LLC Announces Launch of Sister Company Clongen Pharma, LLC in March 2026
August 26, 2025
·
2 min read
Press Releases
Picard Medical, Inc. and SynCardia Systems LLC CEO to Present at CSI Focus D-HF 2025 in Frankfurt, Germany
December 4, 2025
·
2 min read
1 of 32,064
Next
